IMFINZI

Google image searchProduct monograph

Active ingredient

durvalumab, 50 MG/ML

DIN: 02468816

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: ASTRAZENECA CANADA INC

Date: 20-NOV-2017

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF03 — DURVALUMAB (ATC/DDD)

Reference brand drug: Imfinzi

External Links for Imfinzi

Search on Google

• Imfinzi side effects
• Imfinzi dosage
• durvalumab side effects
• durvalumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find imfinzi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.